A dog with cancer named Rosie ignites the latest debate between AI enthusiasts and biologists

A terminally ill dog named Rosie has become an unlikely flashpoint in the intensifying clash between AI evangelists and the scientific establishment, after researchers used machine learning to identify a potential cancer treatment that conventional biology had overlooked. The case exposes a fundamental divide: whether artificial intelligence has finally matured enough to discover solutions human experts miss, or whether it remains a seductive tool prone to dangerous oversimplification of complex disease. As AI companies race to prove their algorithms can revolutionize medicine, Rosie's story suggests the breakthrough moment may hinge less on raw computing power than on whether the scientific community can learn to trust machines as partners rather than threats.

Endpoints News·Apr 8